日本語View as Markdown

Hydrogen as a Potential Therapeutic in Obesity: Targeting the Brain.

肥満における分子状水素の潜在的役割:脳内標的メカニズムの考察

review inhalation not assessed

Abstract

Molecular hydrogen (H2) has been associated with favorable changes in obesity-related metabolic biomarkers in peripheral tissues; however, its direct influence on central nervous system pathways involved in obesity remains unclear. This review article examines several molecular targets located in the hypothalamus and adjacent brain regions that may be modulated by H2 gas in the context of obesity. The author outlines plausible mechanistic pathways through which H2 could interact with central regulatory systems governing energy balance and metabolic homeostasis.

Mechanism

H2 gas may modulate multiple molecular targets in the hypothalamus and surrounding brain regions, potentially influencing central regulatory pathways involved in energy balance and obesity-related metabolic signaling.

Bibliographic

Authors
Ostojic SM
Journal
Trends Endocrinol Metab
Year
2021
PMID
33485760
DOI
10.1016/j.tem.2021.01.002

Tags

Disease:認知機能低下 肥満・メタボリック Mechanism:炎症抑制 ミトコンドリア 酸化ストレス 活性酸素種

Delivery context

For inhalation applications of molecular hydrogen, the lower flammability limit (LFL) deserves careful handling. The classical 4% figure applies to closed-system mixtures; the practical inhalation-environment threshold is 10%. Even pure-hydrogen output (the UFL 75% paradox) passes through the flammable range at the air–gas boundary. High-concentration (66% / 100%) inhalers are documented in the Japanese Consumer Affairs Agency accident-information database and are not recommended.

Safety notes

For inhalation applications of molecular hydrogen, the lower flammability limit (LFL) deserves careful handling. The classical 4% figure applies to closed-system mixtures; the practical inhalation-environment threshold is 10%. Even pure-hydrogen output (the UFL 75% paradox) passes through the flammable range at the air–gas boundary. High-concentration (66% / 100%) inhalers are documented in the Japanese Consumer Affairs Agency accident-information database and are not recommended.

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 33485760. https://h2-papers.org/en/papers/33485760
Source: PubMed PMID 33485760